PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 1, 2012, Pages 103-109

  Alyasiri, Nisreen Sherif ^a   Mehdi, Syed Jafar ^a   Alam, M Shabbir ^a   Ali, Asgar ^a   Mandal, Ashish K ^b   Gupta, Sunita ^c   Singh, Ishwar ^d   Alam Rizvi, M Moshahid ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b MAMC Campus ^*  (India)

^c MAULANA AZAD INSTITUTE OF DENTAL SCIENCES   (India)

^d MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Apoptosis; Immunohistochemistry; Oral cancer; Phospho Akt; PTEN

Indexed keywords

FORMALDEHYDE; PARAFFIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER STAGING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIAN; MALE; MOUTH CARCINOMA; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MOUTH NEOPLASMS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; YOUNG ADULT;

EID: 84857064681     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1077-y     Document Type: Article

References (38)

1. Ali IU, Schriml LM, Dean M (1999) Mutational spectra of PTEN/MMAC1: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 91:1922-1932
2. Altomare DA, Wang HQ, Skele KL, Rienzo AD, Szanto AJ, Godwin A, Testa JR (2004) AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 23:5853-5857 (Pubitemid 39093031)
3. Amornphimoltham P, Sriuranpong V, Patel V, Benavides F, Conti CJ, Sauk J, Sausville EA, Molinolo AA, Gutkind JS (2004) Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 10:4029-4037 (Pubitemid 38812478)
4. Bankfalvi A, Piffko J (2000) Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med 29(7):291-298 (Pubitemid 30459299)
5. Bettendorf O, Piffko J, Bankfalvi A (2004) Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy. Oral Oncol 40(2):110-119 (Pubitemid 38030353)
6. Bowen KA, Doan HQ, Zhou BP, Wang Q, Zhou Y, Rychahou PG, Evers BM (2009) PTEN loss induces epithelial-mesenchymal transition in human colon cancer cells. Anticancer Res 29(11):4439-4449
7. Cappuzzo F, Magrini E, Ceresoli GL, Bartolini S, Rossi E, Ludovini V, Gregorc V, Ligorio C, Cancellieri A, Damiani S, Spreafico A, Paties CT, Lombardo L, Calandri C, Bellezza G, Tonato M, Crinò L (2004) Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 96:1133-1141 (Pubitemid 39207049)
8. Chen Q, Samaranayake LP, Zhou H, Xiao L (2000) Homozygous deletion of the PTEN tumor suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncol 36:95-99
9. DÜrr E-M, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, von Deimling A (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259-2264 (Pubitemid 28220656)
10. Gan YH, Zhang S (2009) PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. Oral Oncol 45(10):150-154
11. Henderson YC, Wang G, Clayman GL (1998) Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas. Laryngoscope 108:1553-1556 (Pubitemid 28465257)
12. Jang KS, Song YS, Jang SH, Min KW, Na W, Jang SM, Jun YJ, Lee KH, Choi D, Paik SS (2010) Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma. Histopathology 56:229-239
13. Kirkegaard T, Witton CJ, McGlynn LM, Tovey SM, Dunne B, Lyon A, Bartlett JM (2005) AKT activation predicts outcome in breast cancer patients treated with tamoxifen. J Pathol 207:139-146 (Pubitemid 41404144)
14. Kreisberg JI, Malik SN, Prihoda TJ, Bedolla RG, Troyer DA, Kreisberg S, Ghosh PM (2004) Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res 64:5232-5236 (Pubitemid 39006542)
15. Kurasawa Y, Shiba M, Nakamura M, Fushimi K, Ishigami T, Bukawa H, Yokoe H, Uzawa K, Tanzawa H (2008) PTEN expression and methylation status in oral squamous cell carcinoma. Oncol Rep 19:1429-1434
16. Lee JI, Soria JC, Hassan KA, El-Naggar AK, Tang X, Liu DD, Hong WK, Mao L (2002) Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg 127:1441-1445
17. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947 (Pubitemid 27148818)
18. Lim J, Kim JH, Paeng JY, Kim MJ, Hong SD, Lee JI, Hong SP (2005) Prognostic value of activated Akt expression in oral squamous cell carcinoma. J Clin Pathol 58:1199-1205 (Pubitemid 41566467)
19. Lu Y, Lin YZ, Lapushin R, Cuevas B, Fang X, Yu SX, Davies MA, Khan H, Furui T, Mao M, Zinner R, Hung MC, Steck P, Siminovitch K, Mills GB (1999) The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and inoikis in breast cancer cells. Oncogene 18:7034-7045 (Pubitemid 30028874)
20. Massarelli E, Liu DD, Lee JJ, El-Naggar AK, Lo Muzio L, Staibano S, De Placido S, Myers JN, Papadimitrakopoulou VA (2005) Akt activation correlates with adverse outcome in tongue cancer. Cancer 104:2430-2436 (Pubitemid 41691564)
21. Mavros A, Hahn M, Wieland I, Koy S, Koufaki ON, Strelocke K, Koch R, Haroske G, Schackert HK, Eckelt U (2002) Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med 31:270-276 (Pubitemid 34667678)
22. Mutter GL, Lin M-C, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP, Eng C (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92:924-930
23. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108 (Pubitemid 40372904)
24. Preacher KJ (2001) Calculation for the Chi-Square test: an interactive tool for Chi-Square tests of goodness of fit and independence (computer software). Available from http://www.quantpsy.org
25. Rizvi MA, Shabbir MA, Ali A, Mehdi SJ, Batra S, Mandal AK (2011) Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population. J Cancer Res Clin Oncol 137(8):1255-1262
26. Rodrigues VC, Moss SM, Tuomainen H (1998) Oral cancer in the UK: to screen or not to screen. Oral Oncol 34:454-465 (Pubitemid 28546858)
27. Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26(3-4):645-662 (Pubitemid 350115112)
28. Saranath D, Bhoite LT, Deo MG (1993) Molecular lesion in human oral cancer: the Indian scene. Eur J Cancer B Oral Oncol 29:107-112 (Pubitemid 23156614)
29. Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR, Schmid KW, Baba A(2008) Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol 48(1):83-90 (Pubitemid 350191996)
30. Shao X, Tandon R, Samara G, Kanki H, Yano H, Close LG, Parsons R, Sato T (1998) Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma. Int J Cancer 77:684-688 (Pubitemid 28341383)
31. Shin Lee J, Seok Kim H, Bok Kim Y, Cheol Lee M, Soo Park C (2003) Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth. J Surg Oncol 84:166-172
32. Snaddon J, Parkinson EK, Craft JA, Bartholomew C, Fulton R (2001) Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br J Cancer 84:1630-1634 (Pubitemid 32612494)
33. Squarize CH, Castilho RM, Pinto DS (2002) Immunohistochemical evidence of PTEN in oral squamous cell carcinoma and its correlation with the histological malignancy grading system. J Oral Pathol Med 31:379-384 (Pubitemid 34973684)
34. Tang JM, He QY, Guo RX, Chang XJ (2005) Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Lung Cancer 51(2):181-191
35. Tsao HS, Zhang X, Benoit E, Haluska FG (1998) Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 16:3397-3402 (Pubitemid 28349682)
36. Weng LP, Brown JL, Eng C (2001) PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum Mol Genet 10:237-242 (Pubitemid 32123982)
37. Yang XF, Xin Y, Mao LL (2008) Clinicopathological significance of PTEN and caspase-3 expressions in breast cancer. Chin Med Sci J 23(2):95-102 (Pubitemid 352000971)
38. Yu Z, Weinberger PM, Sasaki C, Egleston BL, Speier WF IV, Haffty B, Kowalski D, Camp R, Rimm D, Vairaktaris E, Burtness B, Psyrri A (2007) Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer. Cancer Epidemiol Biomarkers Prev 16(3):553-558 (Pubitemid 46548660)